Skip to content

Bioscience PhD Programs

Main Navigation

Hamid Ghandehari

Professor and Chair of Molecular Pharmaceutics, Professor of Biomedical Engineering, and Adjunct Professor of Otolaryngology

Nanomedicine and Drug Delivery

Ghandehari Photo

 

Molecular Biology Program

Biological Chemistry Program

Education

B.S. University of Utah

Ph.D. University of Utah

Links

Lab Page

PubMed Literature Search

Twitter

LinkedIn

hamid.ghandehari@pharm.utah.edu

 

Research

The main focus of research in our laboratory is the development of novel methods for controlled delivery of bioactive agents. Four areas are being explored:

1. Nanotoxicology of dendritic and inorganic constructs

Recent advances in nanotechnology have enabled the fabrication of inorganic nanoconstructs with defined shape, size, and surface functionality. Examples of such constructs include inorganic nanorods and nanospheres. Efforts are directed at evaluating the influence of geometry and surface functionality on biocompatibility and biodistribution of silica and gold nanoparticles, as well as poly(amido amine) dendrimers. In addition, research in this area is focused on design and development of silica nanoparticles with controlled degradation rate for delivery of bioactive agents. For recent articles see [T. Yu, K. Greish, L. McGill, A. Ray, and H. Ghandehari, ACS Nano, 6:2289-2301, 2012;  Herd HL, Bartlett KT, Gustafson JA, McGill LD, Ghandehari H. Biomaterials, 53:574-82, 2015; Hadipour Moghaddam SP, Yazdimamaghani M, Ghandehari H. J Control Release. 2018 Jul 28;282:62-75;Yazdimamaghani M, Moos PJ, Dobrovolskaia MA, Ghandehari H. Nanomedicine. 2018 Dec 7. pii: S1549-9634(18)30564-1;Mohammadpour R, Yazdimamaghani M, Cheney DL, Jedrzkiewicz J, Ghandehari H. J Control Release. 2019 Apr 29. pii: S0168-3659(19)30244-5. doi: 10.1016/j.jconrel.2019.04.041. [Epub ahead of print]

2. Recombinant polymers for drug and gene delivery

Recombinant DNA technology has enabled the synthesis of protein-based polymers with precisely controlled structures. Control over polymer structure at the molecular level has important implications for controlled delivery applications. The potential of recombinant silk-elastinlike protein polymers (SELPs) for matrix-mediated gene delivery is being explored. The idea is that by using recombinant techniques it is possible to systematically correlate polymer structure with gene release and transfer. One focus is on gene therapy applications in the treatment of head and neck cancer. For a recent article see [Price R, Poursaid A, Cappello J, Ghandehari H. J Control Release, ;213:96-102, 2015 Jun 18]. More recent efforts focus on design of recombinant polymers as liquid embolics [Poursaid A, Price R, Tiede A, Olson E, Huo E, McGill L, Ghandehari H, Cappello J. Biomaterials, 57:142-52, 2015 Jul]  and for prophylactic treatment of radiation-induced proctitis [Jensen MM, Jia W, Isaacson KJ, Schults A, Cappello J, Prestwich GD, Oottamasathien S, Ghandehari H. J Control Release. 2017 Oct 10;263:46-56].

3. Water-soluble polymers for targeted delivery

Targeted delivery of bioactive agents by water soluble polymers can increase efficacy and reduce toxicity. The synthesis, characterization and biological evaluation of targetable N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery to angiogenic blood vessels of solid tumors have been investigated– [D. Pike, H. Ghandehari, Advanced Drug Delivery Reviews, 62:167-183, 2010]. More recent efforts focus on gold nanorod-mediated hyperthermia  [A.J. Gormley, N. Larson, S. Sadekar, R. Roinson, A. Ray, and H. Ghandehari, Nano Today, 7:158-167, 2012; N. Larson, A. Gormley, N. Frazier, and H. Ghandehari, Journal of Controlled Release, 170:41-50, 2013]; Robinson R, Gerlach W, Ghandehari H. J Control Release. 2015 Dec 28;220(Pt A):245-52], and High Intensity Focused Ultrasound [Frazier N, Payne A, Dillon C, Subrahmanyam N, Ghandehari H. Nanomedicine. 2017 Apr;13(3):1235-1243] for enhanced delivery of macromolecular therapeutics to solid tumors.

4. Poly(amidoamine) dendrimers for oral delivery

Due to their large size water soluble polymers generally need to be administered intravenously. It would be desirable to develop polymeric carriers that are orally bioavailable. Nano-scale poly(amidoamine) (PAMAM) dendrimers of appropriate size, charge and concentration can be transported across the gastrointestinal epithelial cells with minimal or no toxicity. The influence of variables such as size, charge, surface functionality and drug loading on the mechanism and rate of transport of PAMAM dendrimers across epithelial  barriers has been investigated. More recent efforts focus on in vivo oral bioavailability of PAMAM dendrimers and their transepithelial transport across isolated intestinal tissue. For a recent articles on this topic see [Hubbard D, Enda M, Bond T, Moghaddam SP, Conarton J, Scaife C, Volckmann E, Ghandehari H. Mol Pharm. 2015 Nov 2;12(11):4099-107; Yellepeddi VK, Ghandehari H. Tissue Barriers. 2016 Apr 6;4(2):e1173773]. [Hubbard D, Enda M, Bond T, Moghaddam SP, Conarton J, Scaife C, Volckmann E, Ghandehari H. Mol Pharm. 2015 Nov 2;12(11):4099-107; Yellepeddi VK, Ghandehari H. Tissue Barriers. 2016 Apr 6;4(2):e1173773; Yellepeddi VK, Mohammadpour R, Kambhampati SP, Sayre C, Mishra MK, Kannan RM, Ghandehari H. Int J Pharm. 2018 Jul 10;545(1-2):113-116.]

References

  1. J. Isaacson, B.R. Van Devener, D. B. Steinhauff, M.M. Jensen, J. Cappello, H. Ghandehari. Real-Time Visualization of Temperature-Sensitive Recombinant Polymer Behavior Using Liquid-Cell Transmission Electron Microscopy, Biomacromolecules, Submitted.
  2. M. Jensen, Ø. Hatlevik, X. Wei, K. J. Isaacson, D. Steinhauff, Z.B. Barber, E. Huo, P. Taussky, J. Jedrzkiewicz, J. Cappello, D. Cheney, H. Ghandehari, Silk-Elastinlike. Protein-Based Polymers as Liquid Embolics for Treatment of Cerebral Aneurysms, Bioengineering and Translational Medicine, Submitted.
  3. D.B. Steinhauff, M.M. Jensen, M.W. Talbot, W. Jia, K.J. Isaacson, J. Jedrzkiewicz, J. Cappello, S. Oottamasathien* H. Ghandehari *. Rectal Delivery of Semi-Synthetic Glycosaminoglycan Ethers to Treat Radiation-Induced Proctitis, Journal of Controlled Release. In Review. *Corresponding Co-authors.
  4. M.W. Talbot, D.B. Steinhauff, K.J. Isaacson, J. Cappello, H. Ghandehari, Silk-Elastinlike. Protein-Based Polymers for Controlled Delivery Applications, In Biomimetic Protein Based Elastomers. Royal Society of Chemistry, In press.
  5. Subrahmanyam, H. Ghandehari. Harnessing Extracellular Matrix Biology for Tumor Drug Delivery, Journal of Personalized Medicine, In press.
  6. Kaur, D. Overacker, H. Ghandehari, C. Reilly, R. Paine 3rd, K.E. Kelly (2021) Determining Real-Time Mass Deposition with a Quartz Crystal Microbalance in an Electrostatic, Parallel-Flow, Air-Liquid Interface Exposure System, Journal of Aerosol Science, 151:105653.
  7. Khurana, A. Pulsipher, J. Jedrzkiewicz, S. Ashby, C.E. Pollard, H. Ghandehari, J.A. Alt (2020) Inflammation-Driven Vascular Dysregulation in Chronic Rhinosinusitis. International Forum in Allergy and Rhinology. Online ahead of print.
  8. Khurana, A. Pulsipher, H. Ghandehari, J.A. Alt (2020) Meta-Analysis of Global and High Throughput Public Gene Array Data for Robust Vascular Gene Expression Discovery in Chronic Rhinosinusitis: Implications in Controlled Release, Journal of Controlled Release, S0168-3659(20)30642-8.
  9. Ghandehari, H.-K. Chan, H. Harashima, J.A. MacKay, T. Minko, K. Schenke-Layland, Y. Shen, M.J. Vicent (2020) Advanced Drug Delivery 2020 - Parts 1,2 and 3, Advanced Drug Delivery Reviews, 156: 1-2.
  10. Mohammadpour, D.L. Cheney, J.W. Grunberger, M. Yazdimamaghani, J. Jedrzkiewicz, K.J. Isaacson, M.A. Dobrovolskaia, H. Ghandehari (2020) One-year Chronic Toxicity Evaluation of Single Dose Intravenously Administered Silica Nanoparticles in Mice and Their Ex Vivo Human Hemocompatibility, Journal of Controlled Release, 324:471-481

  11. K.J. Isaacson, M.M. Jensen, D.B. Steinhauff, J.E. Kirklow, R. Mohammadpour, J.W. Grunberger, J. Cappello, H. Ghandehari (2020) Location of Stimuli-Responsive Peptide Sequences within Silk-Elastinlike Protein-Based Polymers Affects Nanostructure Assembly and Drug-Polymer Interactions, Journal of Drug Targeting, 28:766-779

  12. M.M. Jensen, Z.B. Barber, N. Khurana, K.J. Isaacson, D. Steinhauff, B. Green, J. Cappello, A. Pulsipher, H. Ghandehari, J.A. Alt (2020) A Dual-Functional Embolization-Visualization System for Fluorescence Image-Guided Tumor Resection, Theranostics. 10(10):4530-4543. 
  13. H. Ghandehari (2019) ADDR Editors' Collection. Advanced Drug Delivery Reviews, 136-137:1.
  14. S.P. Hadipour Moghaddam, R. Mohammadpour, H. Ghandehari (2019) In Vitro and in Vivo Evaluation of Degradation, Toxicity, Biodistribution, and Clearance of Silica Nanoparticles as a Function of Size, Porosity, Density, and Composition, J Control Release. 311-312:1-15.
  15. V.K. Yellepeddi, H. Ghandehari (2019) Pharmacokinetics of Oral Therapeutics Delivered by Dendrimer-Based Carriers, Expert Opin Drug Deliv. 16(10):1051-1061.
  16. K. Kaur, I.C. Jaramillo, R. Mohammadpour, A. Sturrock, H. Ghandehari, C. Reilly, R. Paine 3rd, K.E. Kelly (2019) Effect of Collection Methods on Combustion Particle Physicochemical Properties and Their Biological Response in a Human Macrophage-Like Cell Line, J Environ Sci Health A Tox Hazard Subst Environ Eng. 54(12):1170-1185
  17. R. Mohammadpour, M.A. Dobrovolskaia, D.L. Cheney, K.F. Greish, H. Ghandehari (2019) Subchronic and Chronic Toxicity Evaluation of Inorganic Nanoparticles for Delivery Applications, Adv Drug Deliv Rev. 144:112-132.
  18. M.M. Jensen, W. Jia, A.J. Schults, K.J. Isaacson, D. Steinhauff, B. Green, B. Zachary, J. Cappello, H. Ghandehari, S. Oottamasathien (2019)  Temperature-responsive Silk-Elastinlike Protein Polymer Enhancement of Intravesical Drug Delivery of a Therapeutic Glycosaminoglycan for Treatment of Interstitial Cystitis/Painful Bladder Syndrome, Biomaterials. 217:119293.
  19. M. Yazdimamaghani, P.J. Moos, H. Ghandehari (2019) Time- And Dose-Dependent Gene Expression Analysis of Macrophage Response as a Function of Porosity of Silica Nanoparticles, Nanomedicine. 21:102041.
  20. G. Battogtokh, O. Gotov, N. Subrahmanyam, Y.T. Ko, H. Ghandehari (2019) GRP78-Targeted HPMA Copolymer-Photosensitizer Conjugate for Hyperthermia-Induced Enhanced Uptake and Cytotoxicity in MCF-7 Breast Cancer Cells, Macromol Biosci. 19(7):e1900032.
  21. R. Mohammadpour, M. Yazdimamaghani, D.L. Cheney, J. Jedrzkiewicz, H. Ghandehari (2019) Subchronic Toxicity of Silica Nanoparticles as a Function of Size and Porosity, J Control Release. 304:216-232.
  22. X. Lv, Y. Zhu, H. Ghandehari, A. Yu, Y. Wang (2019) An ROS-responsive and Self-Accelerating Drug Release Nanoplatform for Overcoming Multidrug Resistance, Chem Commun (Camb). 55(23):3383-3386.
  23. D. Steinhauff, H. Ghandehari (2019) Matrix Mediated Viral Gene Delivery: A Review, Bioconjug Chem. 30(2):384-399.
  24. M. Yazdimamaghani, P.J. Moos, M.A. Dobrovolskaia, H. Ghandehari (2019) Genotoxicity of Amorphous Silica Nanoparticles: Status and Prospects, Nanomedicine. 16:106-125.
  25. R. Mohammadpour, M. Yazdimamaghani, C.A. Reilly, H. Ghandehari (2019) Transient Receptor Potential Ion Channel-Dependent Toxicity of Silica Nanoparticles and Poly(amido Amine) Dendrimers, J Pharmacol Exp Ther. 370(3):751-760.
  26. H. Ghandehari (2018) ADDR Editors' Collection. Advanced Drug Delivery Reviews, 136-137:1.
  27. Z. Gao, S.P. Hadipour Moghaddam, H. Ghandehari, I. Zharov (2018) Synthesis of Water-Degradable Silica Nanoparticles From Carbamate-Containing Bridged Silsesquioxane Precursor, RSC Adv. 178:317-325.
  28. G.W. Liu, A.N. Prossnitz, D.G. Eng, Y. Cheng, N. Subrahmanyam,  J.W. Pippin, R.J. Lamm, C. Ngambenjawong, H. Ghandehari, S.J. Shankland, S.H Pun. Glomerular Disease Augments Kidney Accumulation of Synthetic Anionic Polymers, Biomaterials. 178:317-325.
  29. M. Kanamala, B.D. Palmer, H. Ghandehari, W.R. Wilson, Z. Wu (2018) PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation, Pharm Res. 35(8):154.
  30. M. Yazdimamaghani, Z.B. Barber, S.P. Hadipour Moghaddam, H. Ghandehari (2018) Influence of Silica Nanoparticle Density and Flow Conditions on Sedimentation, Cell Uptake, and Cytotoxicity, Mol Pharm. 15(6):2372-2383.
  31. V.K. Yellepeddi, R. Mohammadpour, S.P. Kambhampati, C. Sayre, M.K. Mishra, R.M. Kannan, H. Ghandehari (2018) Pediatric Oral Formulation of dendrimer-N-acetyl-l-cysteine Conjugates for the Treatment of Neuroinflammation, Int J Pharm. 545(1-2):113-116.
  32. S.P. Hadipour Moghaddam, M. Yazdimamaghani, H. Ghandehari (2018) Glutathione-sensitive Hollow Mesoporous Silica Nanoparticles for Controlled Drug Delivery, J Control Release. 282:62-75. 
  33. M. Yazdimamaghani, P.J. Moos*, and H. Ghandehari* (2018) Global Gene Expression Analysis of Macrophage Response Induced by Nonporous and Porous Silica Nanoparticles, Nanomedicine. 14(2):533-545. *Corresponding Coauthors.
  34. J. Isaacson, M.M. Jensen, A.H. Watanabe, B.E. Green, M.A. Correa, J. Cappello, H. Ghandehari (2017) Self-Assembly of Thermoresponsive Recombinant Silk-Elastinlike Nanogels. Macromolecular Biosciences. 18(1):10.1002/mabi.201700192.
  35. S.P. Hadipour Moghaddam, J. Saikia, M. Yazdimamaghani, H. Ghandehari (2017) Redox-Responsive Polysulfide-Based Biodegradable Organosilica Nanoparticles for Delivery of Bioactive Agents, ACS Applied Materials and Interfaces, 9:21133-21146.
  36. H. Ghandehari (2017) ADDR Editors' Collection. Advanced Drug Delivery Reviews, 108: 1.
  37. M. Jensen, W. Jia, K.J. Isaacson, A. Schults, J. Cappello, G.D. Prestwich, S. Oottamasathien*, H. Ghandehari* (2017) Silk-Elastinlike Protein Polymers Enhance the Efficacy of a Therapeutic Glycosaminoglycan for Prophylactic Treatment of Radiation-Induced Proctitis, Journal of Controlled Release,263:46-56. *Corresponding Coauthors.
  38. K. J. Isaacson, M.M. Jensen, N.B. Subrahmanyam, H. Ghandehari (2017) Matrix-Metalloproteinases as Targets for Controlled Delivery in Cancer: An Analysis of Upregulation and Expression, Journal of Controlled Release, Journal of Controlled Release, 259:62-75.
  39. T.J. Anchordoquy, Y. Barenholz, D. Boraschi, M. Chorny, P. Decuzzi, M.A. Dobrovolskaia, Z.S. Farhangrazi, D. Farrell, A. Gabizon, H. Ghandehari, B. Godin, N.M. La-Beck, J. Ljubimova, S.M. Moghimi, L. Pagliaro, J.H. Park, D. Peer, E. Ruoslahti, N.J. Serkova, D. Simberg (2017) Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions, ACS Nano, 11:12- 18.
  40. K. Zeller Meidell, R. Robinson, A. Vieira-de-Abreu, A.J. Gormley, H. Ghandehari, D.W. Grainger, R. Campbell (2017) RGDfK-Functionalized Gold Nanorods Bind only to Activated Platelets, Journal of Biomedical Materials Research, 105:209-217.
  41. N. Frazier, A. Payne, C. Dillon, N. Subrahmanyam, H. Ghandehari (2017) Enhanced Efficacy of Combination Heat Shock Targeted Polymer Therapeutics with High Intensity Focused Ultrasound, Nanomedicine, 13:1235-1243.
  42. Mohammadpour, S. Safarian*, B. Buckway, H. Ghandehari* (2017) Comparative Endocytosis Mechanisms and Anticancer Effect of HPMA Copolymer- and PAMAM Dendrimer-MTCP Conjugates for Photodynamic Therapy, Macromolecular Biosciences. *Corresponding Coauthors
  43. D.E. Jones, A.M. Lund, H. Ghandehari, J.C. Facelli1 (2016) Molecular Dynamics Simulations in Drug Delivery Research: Calcium Chelation of G3.5 PAMAM Dendrimers, Cogent Chemistry, 2: 1229830.
  44. B. Buckway, H. Ghandehari (2016) Nanotheranostics and In-vivo Imaging, In: Controlled Release Society Series "Nanomedicine, Advances in Delivery Science and Technology", K.A. Howard et al. (eds.), Springer. 
  45. J. Saikia, M. Yazdimamaghani, S.P. Hadipour Moghaddam, H. Ghandehari, Differential Protein Adsorption and Cellular Uptake of Silica Nanoparticles Based on Size and Porosity. ACS Appl Mater Interfaces, 8:34820-34832
  46. B.K. Jung, Y.K. Lee, J. Hong, H. Ghandehari*, Yun CO* (2016) Mild Hyperthermia Induced by Gold Nanorod-Mediated Plasmonic Photothermal Therapy Enhances Transduction and Replication of Oncolytic Adenoviral Gene Delivery. ACS Nano, 10:10533-10543. *Corresponding coauthors.
  47. N. Frazier, A. Payne, J. de Bever, C. Dillon, A. Panda, N. Subrahmanyam, H. Ghandehari (2016) High Intensity Focused Ultrasound Hyperthermia for Enhanced Macromolecular Delivery, Journal of Controlled Release, 241:186-193.
  48. V.K. Yellepeddi, H. Ghandehari (2016) Poly(amido amine) Dendrimers in Oral Delivery, Tissue Barriers. 4:e1173773. 
  49. A. Poursaid, M.M. Jensen, I. Nourbakhsh, M. Weisenberger, J.W. Hellgeth, S. Sampath, J. Cappello, H. Ghandehari (2016) Silk-Elastinlike Protein Polymer Liquid Chemoembolic for Localized Release of Doxorubicin and Sorafenib, Molecular Pharmaceutics, 13:2736-48.
  50. D.E. Jones, H. Ghandehari, J.C. Facelli (2016) A Review of the Applications of Data Mining and Machine Learning for the Prediction of Biomedical Properties of Nanoparticles, Computer Methods Programs Biomed, 132:93-103.
  51. H.-Y. Jeon, S.-H. Jung, Y. M. Kim, H. Ghandehari*, and K.-S. Ha* (2016) Array-Based High-Throughput Analysis of Silk-elastinlike Protein Polymer Degradation and C-Peptide Release by Proteases, Analytical Chemistry, 88:5398-405. *Corresponding coauthors.
  52. N. Mosallaei, A. Mahmoudi, H. Ghandehari, V. K. Yellepeddi, M. R. Jaafari, and B. Malaekeh- Nikouei (2016) Solid Lipid Nanoparticles Containing 7-Ethyl-10-Hydroxycamptothecin (SN38): Preparation, Characterization, In Vitro, and In Vivo Evaluations, European Journal of Pharmaceutics and Biopharmaceutics, 104:42-50. 
  53. A. Poursaid, M.M. Jensen, E. Huo, H. Ghandehari (2016) Polymeric Materials for Embolic and Chemoembolic Applications, Journal of Controlled Release, 240:414-433.
  54. E. Jones, H. Ghandehari, J.C. Facelli (2015) Beilstein Journal of Nanotechnology, Predicting Cytotoxicity of PAMAM Dendrimers Using Molecular Descriptors, 6:1886-96.
  55. H. Herd, J. Gustafson, D. Holt-Casper, D. W. Grainger*, and H. Ghandehari* (2015) Nanoparticle Uptake: The Phagocyte Problem, Nano Today, 10, 487-510. *Corresponding coauthors.
  56. R. Robinson, W. Gerlach, and H. Ghandehari (2015) Comparative Effect of Gold Nanorods and Nanocages for Prostate Tumor Hyperthermia, Journal of Control Release. 220(Pt A):245-52.
  57. D. Hubbard, M. Enda, T. Bond, S.P. Moghaddam, J. Conarton, C. Scaife, E. Volckmann, and H. Ghandehari (2015) Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue, Molecular Pharmaceutics, 12:4099-107.
  58. H Ghandehari (2015) ADDR Editor's Collection. Advanced Drug Delivery Reviews, 91:1-2.
  59. D Hubbard, T. Bond, and H. Ghandehari (2015) Regional Morphology and Transport of PAMAM Dendrimers Across Isolated Rat Intestinal Tissue. Macromolecular Biosciences, 15:1735-43 . 
  60. Price R, Poursaid A, Cappello J, Ghandehari H (2015) In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy. Journal of Controlled Release, Jun 18. pii: S0168-3659(15)00629-X. doi: 10.1016/j.jconrel.2015.06.022. 
  61. Frazier N, Ghandehari H. (2015) Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors. Biotechnology and Bioengineering, May 20. doi: 10.1002/bit.25653. 
  62. Poursaid A, Price R, Tiede A, Olson E, Huo E, McGill L, Ghandehari H, Cappello J (2015) In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization. Biomaterials, 57:142-52
  63. Herd HL, Bartlett KT, Gustafson JA, McGill LD, Ghandehari H (2015) Macrophage silica nanoparticle response is phenotypically dependent. Biomaterials, 53:574-8
  64. Jung SH, Choi JW, Yun CO, Kim SH, Kwon IC, Ghandehari H (2015) Direct observation of interactions of silk-elastinlike protein polymer with adenoviruses and elastase.  Molecular Pharmaceutics, 12(5):1673-9
  65. Frazier N, Robinson R, Ray A, Ghandehari H (2015) Effects of heating temperature and duration by gold nanorod mediated plasmonic photothermal therapy on copolymer accumulation in tumor tissue. Molecular Pharmaceutics, 12(5):1605-14
  66. Larson N, Roberts S, Ray A, Buckway B, Cheney DL, Ghandehari H (2014) In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer. Macromolecular Bioscience, 14(12):1735-47
  67. Price R, Poursaid A, Cappello J, Ghandehari H (2014) Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels. Journal of Controlled Release, 195:92-8
  68. Hubbard D, Ghandehari H, Brayden DJ (2014) Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers. Biomacromolecules, 15(8):2889-95
  69. Jung SH, Choi JW, Yun CO, Yhee JY, Price R, Kim SH, Kwon IC, Ghandehari H (2014) Sustained local delivery of oncolytic short hairpin RNA adenoviruses for treatment of head and neck cancer. Journal of Gene Medicine, 16(5-6):143-52
  70. Price R, Poursaid A, Ghandehari H (2014) Controlled release from recombinant polymers. Review. Journal of Controlled Release, 190:304-13
  71. Astashkina AI, Jones CF, Thiagarajan G, Kurtzeborn K, Ghandehari H, Brooks BD, Grainger DW (2014) Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model. Biomaterials, 35(24):6323-31
  72. Buckway B, Frazier N, Gormley AJ, Ray A, Ghandehari H (2014) Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors. Nuclear Medicine and Biology, 41(3):282-9
  73. Buckway B, Wang Y, Ray A, Ghandehari H (2014) In vitro evaluation of HPMA-copolymers targeted to HER2 expressing pancreatic tumor cells for image guided drug delivery. Macromolecular Bioscience, 14(1):92-9
  74. Varongchayakul N, Johnson S, Quabili T, Cappello J, Ghandehari H, Solares Sde J, Hwang W, Seog J (2013) Direct observation of amyloid nucleation under nanomechanical stretching. American Chemical Society Nano, 7(9):7734-43
  75. Buckway B, Wang Y, Ray A, Ghandehari H (2013) Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors. International Journal of Pharmaceutics, 456(1):202-11
  76. Sadekar S, Thiagarajan G, Bartlett K, Hubbard D, Ray A, McGill LD, Ghandehari H (2013) Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. International Journal of Pharmaceutics, 456(1):175-85
  77. Larson N, Yang J, Ray A, Cheney DL, Ghandehari H, Kopeček J (2013) Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment. International Journal of Pharmaceutics, 454(1):435-43
  78. Moos PJ, Honeggar M, Malugin A, Herd H, Thiagarajan G, Ghandehari H (2013) Transcriptional responses of human aortic endothelial cells to nanoconstructs used in biomedical applications. Molecular Pharmacology, 10(8):3242-52
  79. Sadekar S, Linares O, Noh G, Hubbard D, Ray A, Janát-Amsbury M, Peterson CM, Facelli J, Ghandehari H (2013) COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICE. Drug Deliv Transl Res, 3(3):260-271
  80. Larson N, Gormley A, Frazier N, Ghandehari H (2013) Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. Journal of Controlled Release, 170(1):41-50
  81. Thiagarajan G, Greish K, Ghandehari H (2013) Charge affects the oral toxicity of poly(amidoamine) dendrimers. European Journal of Pharmaceutics and Biopharmaceutics, 84(2):330-4
  82. Herd H, Daum N, Jones AT, Huwer H, Ghandehari H, Lehr CM (2013) Nanoparticle geometry and surface orientation influence mode of cellular uptake. American Chemical Society Nano, 7(3):1961-73
  83. Gustafson JA, Price RA, Frandsen J, Henak CR, Cappello J, Ghandehari H (2013) Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer. Biomacromolecules, 14(3):618-25
  84. Thiagarajan G, Sadekar S, Greish K, Ray A, Ghandehari H (2013) Evidence of oral translocation of anionic G6.5 dendrimers in mice. Molecular Pharmacology, 10(3):988-98
  85. Gormley AJ, Larson N, Banisadr A, Robinson R, Frazier N, Ray A, Ghandehari H (2013) Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. Journal of Controlled Release, 166(2):130-8
  86. Lee VH, Ghandehari H (2013) Advanced drug delivery perspectives and prospects. Preface. Advanced Drug Delivery Reviews, 65(1):1-2
  87. Jones CF, Campbell RA, Brooks AE, Assemi S, Tadjiki S, Thiagarajan G, Mulcock C, Weyrich AS, Brooks BD, Ghandehari H, Grainger DW (2012) Cationic PAMAM dendrimers aggressively initiate blood clot formation. American Chemical Society Nano, 6(11):9900-10
  88. Johnson S, Ko YK, Varongchayakul N, Lee S, Cappello J, Ghandehari H, Lee SB, Solares SD, Seog J (2012) Directed patterning of the self-assembled silk-elastin-like nanofibers using a nanomechanical stimulus. Chemical Communications (Cambridge), 48(86):10654-6
  89. Greish K, Thiagarajan G, Ghandehari H (2012) In vivo methods of nanotoxicology. Methods Molecular Biology, 926:235-53
  90. Gormley AJ, Larson N, Sadekar S, Robinson R, Ray A, Ghandehari H (2012) Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. Nano Today, 7(3):158-167
  91. Larson N, Ghandehari H (2012) Polymeric conjugates for drug delivery. Chemistry of Materials, 24(5):840-853
  92. Yu T, Hubbard D, Ray A, Ghandehari H (2012) In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. Journal of Controlled Release, 163(1):46-54
  93. Jones CF, Campbell RA, Franks Z, Gibson CC, Thiagarajan G, Vieira-de-Abreu A, Sukavaneshvar S, Mohammad SF, Li DY, Ghandehari H, Weyrich AS, Brooks BD, Grainger DW (2012) Cationic PAMAM dendrimers disrupt key platelet functions. Molecular Pharmacology, 9(6):1599-611
  94. Yu T, Greish K, McGill LD, Ray A, Ghandehari H (2012) Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity their vasculature effect and tolerance threshold. American Chemical Society Nano, 6(3):2289-301
  95. Frandsen JL, Ghandehari H (2012) Recombinant protein-based polymers for advanced drug delivery. Chemical Society Reviews, 41(7):2696-706
  96. Sadekar S, Ghandehari H (2012) Transepithelial transport and toxicity of PAMAM dendrimers implications for oral drug delivery. Advanced Drug Delivery Reviews, 64(6):571-88
  97. Price R, Gustafson J, Greish K, Cappello J, McGill L, Ghandehari H (2012) Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery. International Journal of Pharmaceutics, 427(1):97-104
  98. Greish K, Thiagarajan G, Herd H, Price R, Bauer H, Hubbard D, Burckle A, Sadekar S, Yu T, Anwar A, Ray A, Ghandehari H (2012) Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology, 6(7):713-23
  99. Gormley AJ, Malugin A, Ray A, Robinson R, Ghandehari H (2011) Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment. Journal of Drug Targeting, 19(10):915-24
  100. Larson N, Greish K, Bauer H, Maeda H, Ghandehari H (2011) Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin. International Journal of Pharmaceutics, 420(1):111-7
  101. Gormley AJ, Greish K, Ray A, Robinson R, Gustafson JA, Ghandehari H (2011) Gold nanorod mediated plasmonic photothermal therapy a tool to enhance macromolecular delivery. International Journal of Pharmaceutics, 415(1-2):315-8
  102. Yu T, Malugin A, Ghandehari H (2011) Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. American Chemical Society Nano, 5(7):5717-28
  103. Herd HL, Malugin A, Ghandehari H (2011) Silica nanoconstruct cellular toleration threshold in vitro. Journal of Controlled Release, 153(1):40-8
  104. Arnida, Janát-Amsbury MM, Ray A, Peterson CM, Ghandehari H (2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. European Journal of Pharmaceutics and Biopharmaceutics, 77(3):417-23
  105. Gustafson JA, Ghandehari H (2010) Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy. Advanced Drug Delivery Reviews, 62(15):1509-23
  106. Goldberg DS, Ghandehari H, Swaan PW (2010) Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia. Pharmaceutical Research, 27(8):1547-57
  107. Pike DB, Ghandehari H (2010) HPMA copolymer-cyclic RGD conjugates for tumor targeting. Advanced Drug Delivery Reviews, 62(2):167-83
  108. Borgman MP, Ray A, Kolhatkar RB, Sausville EA, Burger AM, Ghandehari H (2009) Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy. Pharmaceutical Research, 26(6):1407-18
  109. Nan A, Bai X, Son SJ, Lee SB*, Ghandehari H* (2008) Cellular uptake and cytotoxicity of silica nanotubes. Nano Letters, 8(8):2150-4
  110. Dandu R, Ghandehari H (2007) Delivery of Bioactive Agents from Recombinant Polymers. Progress in Polymer Science, 32:1008-1030
  111. Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H (2007) Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharmaceutical Research, 24(11):2138-45
  112. Mitra A, Coleman T, Borgman M, Nan A, Ghandehari H, Line BR (2006) Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting. Journal of Controlled Release, 114(2):175-83
  113. Son SJ, Bai X, Nan A, Ghandehari H, Lee SB (2006) Template synthesis of multifunctional nanotubes for controlled release. Journal of Controlled Release, 114(2):143-52
Last Updated: 4/16/24